Klotho‑Mitochondrial ROS Axis Drives Telomeric Informational Entropy Independent of Cell Division

Core Hypothesis

Telomere length reflects the accumulation of oxidative lesions (informational entropy) rather than a simple mitotic counter. Declining soluble Klotho elevates mitochondrial ROS, which directly damages telomeric DNA and destabilizes shelterin complexes, leading to telomere attrition in non‑dividing progenitor populations.

Mechanistic Reasoning

• Klotho suppresses mitochondrial ROS by upregulating SOD2 and catalase via the Nrf2 pathway (4, 5).
• Oxidative stress generates 8‑oxoguanine (8‑oxoG) preferentially in telomeric repeats because of their high guanine content and open G‑quadruplex chromatin (2).
• 8‑oxoG lesions impede TRF2 binding and activate ATM‑dependent DNA‑damage response, causing telomere shortening independent of replication fork passage.
• Soluble Klotho also enhances AKT‑mediated phosphorylation of TERT, transiently boosting telomerase activity in progenitor cells when ROS are low (7).

Thus, Klotho loss shifts the balance toward oxidative "informational entropy" at telomeres, while Klotho repletion restores fidelity.

Testable Predictions

1. Inverse correlation: In aged Klotho−/− mice, telomere length in muscle satellite cells (Pdgfra+) will negatively correlate with mitochondrial MitoSOX signal, independent of Ki‑67 proliferation index.
2. Antioxidant rescue: Treatment with N‑acetylcysteine (NAC) will restore telomere length in Klotho−/− progenitors without altering cell‑cycle kinetics.
3. Mitochondrial‑specific ROS reduction: Overexpression of mitochondria‑targeted catalase (mCAT) in Klotho−/− mice will normalize telomere attrition to wild‑type levels.
4. Human progenitor validation: CRISPRi‑mediated KLOTHO knockdown in cultured mesenchymal stem cells will increase telomeric 8‑oxoG (measured by OGG1‑IP‑qPCR) and shorten telomeres; addition of recombinant Klotho‑Fc will reverse both effects.
5. Falsification criterion: If manipulation of mitochondrial ROS (scavenging or mCAT) fails to alter telomere length despite confirmed changes in oxidative stress, the hypothesis is falsified.

Experimental Outline

• Animal cohorts: Young (3 mo), aged (24 mo) WT and Klotho−/−; subgroups receiving NAC (1 g/L drinking water) or mCAT AAV9.
• Readouts: qFISH for telomere length, Telomere‑specific 8‑oxoG assay, mitochondrial ROS (MitoSOX flow), proliferation (Ki‑67/IHC), senescence (p16^INK4a^).
• Human assay: Primary MSC donors, KLOTHO siRNA, treatment with Klotho‑Fc (100 ng/mL), assessment after 7 days.

Potential Impact

Linking the Klotho‑FGF23 endocrine axis to telomere maintenance reframes aging as a manageable redox‑information problem, opening therapeutic avenues that target mitochondrial ROS rather than cell‑cycle manipulation.